3 Reasons to Sell NEO and 1 Stock to Buy Instead [Yahoo! Finance]
NeoGenomics, Inc. (NEO)
Last neogenomics, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.neogenomics.com
Company Research
Source: Yahoo! Finance
This may have investors wondering how to approach the situation. Is now the time to buy NeoGenomics, or should you be careful about including it in your portfolio? Check out our in-depth research report to see what our analysts have to say, it's free Even with the cheaper entry price, we're sitting this one out for now. Here are three reasons why NEO doesn't excite us and a stock we'd rather own. Operating a network of CAP-accredited and CLIA-certified laboratories across the United States and United Kingdom, NeoGenomics (NASDAQ:NEO) provides specialized cancer diagnostic testing services, including genetic analysis, molecular testing, and pathology consultation for oncologists and healthcare providers. Analyzing the long-term change i
Read more
Impact Snapshot
Event Time:
NEO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NEO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NEO alerts
High impacting NeoGenomics, Inc. news events
Weekly update
A roundup of the hottest topics
NEO
News
- NeoGenomics Appoints Warren Stone as President & Chief Operating OfficerBusiness Wire
- NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of PathlineBusiness Wire
- NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at Piper Sandler from $21.00 to $18.00. They now have an "overweight" rating on the stock.MarketBeat
- NeoGenomics to Participate in Upcoming Investor ConferencesBusiness Wire
- NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at Bank of America Co. from $19.00 to $16.00. They now have a "neutral" rating on the stock.MarketBeat
NEO
Earnings
- 2/18/25 - Beat
NEO
Sec Filings
- 3/19/25 - Form 8-K/A
- 3/18/25 - Form 8-K
- 3/18/25 - Form SCHEDULE
- NEO's page on the SEC website